High-Throughput Screening Services Market Report 2026

High-Throughput Screening Services Market Overview

• High-Throughput Screening Services market size has reached to $23.02 billion in 2025 • Expected to grow to $39.06 billion in 2030 at a compound annual growth rate (CAGR) of 11.2% • Growth Driver: Rising Prevalence Of Chronic And Complex Diseases Fueling The Growth Of The Market Due To Increased Demand For Accelerated Drug Discovery And Target Identification • Market Trend: Advancements in Ultra-High-Speed, Multiparametric Screening Technologies Accelerating Drug Discovery Efficiency • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under High-Throughput Screening Services Market?

High-throughput screening (HTS) services are laboratory services that use automated technologies to rapidly test thousands to millions of chemical, biological, or genetic compounds for activity against specific biological targets. These services often employ robotics, data analytics, and miniaturized assays to accelerate drug discovery and target identification. They help to efficiently identify potential drug candidates or bioactive compounds for further development in pharmaceutical and biotechnology research. The main types of high-throughput screening services include instruments, reagents and kits, and services. Instruments refer to automated platforms designed to rapidly test large numbers of biological or chemical compounds for activity, toxicity, or other relevant properties. These services use technologies such as ultra-high-throughput screening (uHTS), cell-based assays, lab-on-a-chip systems, and label-free technology. They are applied across areas including target identification, primary screening, and toxicology, and are used by end users including pharmaceutical and biotechnology firms, academia and research institutes, and contract research organizations (CROs).

What Is The High-Throughput Screening Services Market Growth Forecast?

The high-throughput screening services market size is expected to see rapid growth in the next few years. It will grow to $39.06 billion in 2030 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to increasing investments in precision drug discovery, rising focus on biologics and complex targets, expansion of personalized medicine research, growing use of AI-assisted screening workflows, increasing outsourcing of screening services to CROs. Major trends in the forecast period include increasing use of automated robotic screening platforms, rising demand for ultra-high-throughput screening services, growing adoption of cell-based and label-free assays, expansion of AI-driven data analysis in drug discovery, enhanced focus on accelerating hit-to-lead identification.

Global High-Throughput Screening Services Market Segmentation

1) By Products And Services: Instruments; Reagents And Kits; Services 2) By Technology: Ultra-high-throughput Screening; Cell-based Assays; Lab-on-a-chip; Label-free Technology 3) By Application: Target Identification; Primary Screening; Toxicology 4) By End User: Pharmaceutical And Biotechnology Firms; Academia And Research Institutes; Contract Research Organizations Subsegments: 1) By Instruments: Automated Screening Systems; Liquid Handling Systems; Detection And Imaging Systems; Data Acquisition Systems 2) By Reagents And Kits: Assay Reagents; Screening Kits; Cell Based Reagents; Detection Reagents 3) By Services: Assay Development And Optimization Services; Primary Screening Services; Hit Confirmation And Validation; Data Analysis And Bioinformatics Support; Specialized Screens; Project Management And Reporting

What Is The Driver Of The High-Throughput Screening Services Market?

The growing prevalence of chronic and complex diseases is expected to propel the growth of the high-throughput screening services market. Chronic and complex diseases are long-term conditions that involve multiple biological pathways, persist over extended periods, and typically require continuous management rather than short-term treatment. The prevalence of these diseases is rising largely due to aging global populations, lifestyle-related risk factors, and improved disease detection, which together are increasing the burden on healthcare systems and driving demand for advanced therapeutic solutions. High-throughput screening (HTS) services support research into chronic and complex diseases by enabling the rapid and simultaneous evaluation of large numbers of compounds against biological targets. This capability accelerates early-stage drug discovery, improves target identification, and supports the development of more effective therapies for multifactorial and long-term conditions. For instance, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency, approximately 76.4% of adults in the United States, representing more than 194 million people—reported having at least one chronic condition in 2023, while 51.4% (around 131 million people) reported multiple chronic conditions. Therefore, the growing prevalence of chronic and complex diseases is driving the growth of the high-throughput screening services industry.

Key Players In The Global High-Throughput Screening Services Market

Major companies operating in the high-throughput screening services market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Corning Incorporated, Eurofins Scientific SE, Charles River Laboratories International Inc., Revvity Inc., Bio-Rad Laboratories Inc., Hamilton Company, Tecan Group Ltd., GenScript Biotech Corporation, Promega Corporation, Molecular Devices LLC, ShanghAI Medicilon Inc., Sygnature Discovery Limited, Selvita S.A., Cayman Chemical Company, Creative Bioarray Inc., Axxam S.p.A., Axcelead Inc., Creative Biolabs Inc., Enamine Ltd., Aurora Biomed Inc.

Global High-Throughput Screening Services Market Trends and Insights

Major companies operating in the high-throughput screening services market are focusing on innovation in miniaturized and high-density assays such as ultra-high screening speed with up to 27 detection channels to enable faster, large-scale multiparametric analysis and accelerate drug discovery workflows. Ultra-high screening speed with up to 27 detection channels refers to the ability to rapidly analyze multiple biological parameters simultaneously, increasing data output and efficiency in high-throughput screening studies. For instance, in May 2024, Evotec SE, a Germany-based drug discovery and development services company, introduced comprehensive high-throughput screening services as part of its integrated early discovery platform. Evotec conducts large-scale biochemical and cell-based HTS campaigns using highly automated, miniaturized assay systems and advanced data analytics. The company supports pharmaceutical and biotechnology partners by rapidly identifying hit compounds and optimizing lead selection, thereby accelerating early-stage drug discovery programs.

What Are Latest Mergers And Acquisitions In The High-Throughput Screening Services Market?

In January 2023, Charles River Laboratories International, Inc., a US-based contract research organization (CRO), acquired SAMDI Tech, Inc. for an undisclosed amount.  Through this acquisition, Charles River Laboratories aims to strengthen its drug discovery capabilities by integrating SAMDI Tech’s proprietary, label-free mass spectrometry–based high-throughput screening technologies, enabling faster hit identification, higher-quality data generation, and accelerated early-stage drug development timelines. SAMDI Tech, Inc. is a US-based biotechnology company specialized in advanced mass spectrometry–driven assay platforms and high-throughput screening services for drug discovery.

Regional Insights

North America was the largest region in the high-throughput screening services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the High-Throughput Screening Services Market?

The high-throughput screening services market includes revenues earned by entities through development and optimization, compound library screening, target identification and validation, automated robotic screening, data analysis and reporting, hit-to-lead evaluation, and consulting services for drug discovery programs. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the High-Throughput Screening Services Market Report 2026?

The high-throughput screening services market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the high-throughput screening services industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.